Real-Time
Market Intelligence

DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in August and September: Three Part Advisors Midwest (August 26th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Tuesday August 26th at 11:30 AM CT. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Cantor Global Healthcare Conference (September 3rd) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside cha

Kfar Saba, Israel, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced that it has received a purchase order for its advanced Counter-Unmanned Aerial Systems (C-UAS) solution from a defense entity. This is another achievement for ParaZero in its continued expansion into the defense market and the rapidly growing counter-drone market specifically. According to recent market research, the global anti drone market size was valued at $2.4B in 2024. The market is projected to grow from $3.1B i

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Aug. 18, 2025 /CNW/ - Iocaste Ventures Inc. ("Iocaste") (TSXV:ICY), a capital pool company, and TenX Protocols Inc. (formerly, Layer X Inc.) ("TenX Protocols") are pleased to announce that they have entered into a business combination agreement dated August 18, 2025 (the "Definitive Agreement") which outlines the terms and conditions pursuant to which Iocaste and TenX Protocols will complete a transaction that will result in a reverse takeover of Iocaste by the shareholders of TenX Protocols (the "Transaction") by way of a three-cornered amalgamation between Iocaste, TenX Protocol, an

TORONTO, Aug. 18, 2025 /PRNewswire/ - DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (NASDAQ:DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance, today announced the launch of the DeFi Technologies Insights Symposium, with the inaugural session to take place in Frankfurt, Germany, on September 25, 2025. The DeFi Technologies Insights Symposium is a new global initiative designed to foster high-level, in-person discussions around the future of finance. Backed by DeFi Techno

H.C. Wainwright upgraded Savara from Neutral to Buy and set a new price target of $5.00

Lake Street upgraded Evolv Technologies Holdings from Hold to Buy and set a new price target of $9.00

DZ Bank downgraded Applied Materials from Hold to Sell and set a new price target of $150.00

Evercore ISI initiated coverage of Skye Bioscience with a rating of Outperform and set a new price target of $10.00

4 - AGREE REALTY CORP (0000917251) (Issuer)

4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)

4 - Community West Bancshares (0001127371) (Issuer)

4 - SmartRent, Inc. (0001837014) (Issuer)

3 - Seaport Entertainment Group Inc. (0002009684) (Issuer)

4 - Soho House & Co Inc. (0001846510) (Issuer)

4 - Soho House & Co Inc. (0001846510) (Issuer)

4 - SMITH MICRO SOFTWARE, INC. (0000948708) (Issuer)

8-K - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)

6-K - Freightos Ltd (0001927719) (Filer)

8-K - Serve Robotics Inc. /DE/ (0001832483) (Filer)

8-A12B - Vistra Corp. (0001692819) (Filer)

For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

Expedites Serve's adoption of end‑to‑end learned autonomy to unlock safer, faster navigationVinod Khosla to join Serve's advisory board SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (NASDAQ:SERV), a leading autonomous sidewalk delivery company ("Serve"), has acquired Vayu Robotics, Inc. ("Vayu"), a pioneer in urban robot navigation using large-scale AI models. The strategic acquisition marks a milestone in Serve's mission to redefine the future of autonomous delivery. As "physical AI" gains unprecedented momentum, acquiring Vayu positions Serve at the forefront of this paradigm shift in the robotics industry. Serve's delivery robots have set the

TORONTO, Ontario and NEW YORK, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (Nasdaq/TSX:BITF) (the "Company"), a global energy and compute infrastructure company, today announced that the Board of Directors (the "Board") has unanimously approved the appointment of Wayne Duso to the Company's Board, effective immediately. With the appointment of Mr. Duso, Bitfarms' Board is now comprised of seven directors, six of whom are independent. Mr. Duso is a distinguished senior engineering and product executive with over 25 years' experience developing enterprise technologies. He is renowned for his leadership in cloud storage systems that support large-scale data centers, making it eas

WESTMINSTER, Colo., Aug. 18, 2025 /PRNewswire/ -- Trimble (NASDAQ:TRMB) today announced that Chief Accounting Officer (CAO) Julie Shepard will retire from the company in early 2026 after more than 18 years of service to Trimble shareholders. The company has named Kenny Bement as its new CAO effective September 2025. Julie and Kenny will work together over the next six to eight months to ensure a seamless transition. Julie will continue to support the auditor transition for the 2025 financial statements. Kenny brings to Trimble more than two decades of experience in financial r

Soho House & Co (NYSE:SHCO), today announced the appointment of Mr. Neil Thomson as the Company's new Chief Financial Officer, effective August 18, 2025. Mr. Thomson, who will be based in the Company's London Head Office, will succeed Mr. Thomas Allen, who will remain with the Company through August 29, 2025 to help ensure a smooth transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250818008221/en/Neil Thomson, Chief Financial Officer, Soho House & Co Mr. Thomson is a 30-year hospitality company operations and finance veteran, having served most recently as Chief Financial Officer of Tasty Restaurant Group, a leading pri

DUBLIN and SHANGHAI, Aug. 18, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD) today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before U.S. markets open on Monday, August 25, 2025. The Company's management will hold an earnings conference call at 7:30 AM ET on August 25, 2025 (12:30 PM IST and 7:30 PM HKT on the same day). The conference call will be webcast live at https://investor.pddholdings.com/investor-events. The webcast will be available for replay at the same website following the conclusion of the call. About PDD Holdings: PDD Holdings is a multinational commerce group that o

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that its board of directors has declared a monthly ordinary dividend of $0.2575 per share of common stock, which is the equivalent of an annualized dividend of $3.09 per share. The dividend is payable in cash on September 15, 2025 to shareholders of record at the close of business on August 29, 2025. About SL Green Realty Corp. SL Green Realty Corp., Manhattan's largest office landlord, is a fully integrated real estate investment trust, or REIT, that is focused primarily on acquiring, managing and maximizing the value of Manhattan commercial properties. As o

Second quarter revenue up 31% year-over-year, exceeding management expectationsUpdated full-year outlook: increased transaction forecast and tightened financial metrics rangesBARCELONA, Spain, Aug. 18, 2025 /PRNewswire/ -- Freightos Limited (NASDAQ:CRGO), the leading vendor-neutral digital booking and payment platform for the international freight industry, today reported its financial results for the quarter ended June 30, 2025.     "Freightos continues to solidify its position as a leader in the end-to-end digital transformation of the international freight industry, achieving robust second-quarter results with a 31% year-over-year revenue increase. We have revised our full-year Transacti

SHANGHAI, Aug. 18, 2025 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before U.S. markets open on August 21, 2025. The Company will hold an earnings conference call at 8:00 A.M. Eastern Time on Thursday, August 21, 2025 (8:00 P.M. Beijing Time on the same day) to discuss its financial results. Management's prepared remarks and the question-and-answer session will be conducted in English and Mandarin. Dial-in details for the earnings conference call a

SC 13D/A - ALLIANCEBERNSTEIN HOLDING L.P. (0000825313) (Subject)

SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

SC 13D/A - INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ (0000949961) (Subject)

SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan